Inflawell(®) improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial

AIMS: COVID-19 is a significant global threat to public health. Despite the availability of vaccines and anti-viral drugs, there is an urgent need for alternative treatments to help prevent and/or manage COVID-19 symptoms and the underlying dysregulated immune response. We hypothesized that administ...

Descripción completa

Detalles Bibliográficos
Autores principales: Barzin Tond, Sepideh, Balenci, Laurent, Khajavirad, Nasim, Salehi, Mohammadreza, Tafakhori, Abbas, Shahmohammadi, Mohammad Reza, Ghiasvand, Fereshteh, Jafari, Sirous, Abolghasemi, Sara, Mokhtari, Farzad, Mahmoodi Baram, Somayyeh, Zarei, Tayebe, Kazemi, Davood, Mohammadnejad, Esmaeil, Shah-Hosseini, Akram, Haghbin Toutounchi, Alireza, Fallah, Soudabeh, Riazi, Ali, Karima, Saeed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867130/
https://www.ncbi.nlm.nih.gov/pubmed/35201518
http://dx.doi.org/10.1007/s10787-022-00928-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867130/
https://www.ncbi.nlm.nih.gov/pubmed/35201518
http://dx.doi.org/10.1007/s10787-022-00928-w

Ejemplares similares